holland taylor. and have an awesome winesday. be with us tomorrow for thirsty thursday. >> i love it. my mission is simple, to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere, and i promise to help you find it. "mad money" starts now! hey, i'm cramer. welcome to "mad money." welcome to cramerica. friends. i'm just trying to make you some money. my job is not just to entertain you, but to educate and teach you. so call me at 1-800-743-cnbc or tweet me @jimcramer. this should be a halcyon time for so many different stock groups. instead, it's a treacherous time where some things are working, but other things that should be working are downright toxic.

should be on fire right now, but instead they are houses on fire. and there's no letting up in the flames even as the averages rebounded hard today after opec announced it might cut back half a million barrels of production in november. i think this is more of the same where they rumor the price higher, which worked again, taking oil up almost 5%, and then kind of do nothing meaningful, which is also what keeps happening on these kinds of deals. nevertheless, as i have said over and over again to you, anything that drives oil higher takes stocks higher, and that's the dow ultimately gaining 111 points, s&p climbing 0.53%, nasdaq advancing 0.24%. the linkage remains that great even as i urge you to be skeptical of any so-called deals when there is such a worldwide glut of oil, one that would need millions of barrels to be cut, not less than a million. this means the amount will not give you a lasting impact. i want to talk about what's happening with these beleaguered groups i mentioned earlier as

expected not too long ago. let's start with the banks. it was clearly the stated policy of the federal reserve coming into 2016 to raise interest rates several time because the emergency fund rates levels that we came into the year with are certainly not in keeping with the rate of job growth in the country. and the banks make a fortune when rates go higher, so they were very favored. now, you could argue that given the amount of job creation, which is so strong, and the price of housing, which is so robue high as three quarters of a percent, if not more from where they were a year ago. instead we've only had one hike, that december hike, because there's so much else that's not going well in this country and the world. for example, we got a durable goods number this morning that showed almost no growth whatsoever. that's on top of various weak pmi numbers and retail sales growth that's pretty sickly. of course the rest of the world is cutting interest rates.

making our exports even more anemic than they already are. meanwhile inflation is pretty much nonexistent. digitization keeps costs low as do bountiful harvests that have caused intense food deflation. we've rarely seen such pricing pressure on foodstuffs, and it's impacting every aisle of the supermarkets, including the once hot natural and organic section. it doesn't help that china almost imploded, and then brexit fever swept through europe, and the price of oil repeatedly threatened to break down, at least until opec rumored it higher like they did today with word of a small and frankly suspicious production freeze. but oil did break down back in february causing the fed to put its plans on hold for what looked like an ideal time. if it isn't one thing, it's another. that might as well be the fed's mantra for doing nothing in 2016. and that caused immense pain for the banks since they're the group that had the most to gain from rate hikes. it just didn't happen. and their soon-to-be reported numbers, i am telling you i think will most likely prove to be too high, which will cause -- >> sell, sell, sell.

there had always been a couple of offsets to the banks' weak net interest margins, for example, augmenting their profits by offering more services to each customer, services with a steady stream of fees. that was called the virtuous cycle of cross-selling, and the more aggressive you were, the more accounts opened per person, the greater the profit for the bank. but now because of multiple transgressions by wells fargo, admitted multiple transgressions where employees opened far more accounts than st knew about, cross-selling has become a vicious cycle downward that the banks somehow have to stem. of course that's a pretty bloodless way of saying it. what we're talking about is taking away the premium that wells fargo stock has enjoyed for years versus other banks because of what is now regarded as fraudulent cross-selling. will it take its toll at the top? wells fargo's board of directors has managed to claw back some of the compensation coming to ceo john stumpf and the now retired carrie tolstedt, this so far

the lawmakers who are set to grill stumpf tomorrow will be appeased. if there isn't some break in this story's momentum, it's possible that stumpf could lose his job as we actually talked about when he was here on the set, and the cross-selling that helped profitability will lose its champion. either way, no one is going to pay as much for the stock of what was once regarded as the premium bank, which then trickles down to what the whole market will pay for all the other banks. wells fargo was the gold standard. that is no longer the case. it gets worse. the european banks are a disaster. the london banks, which seemed to be finding their footing, have seen their core franchises obliterated by brexit. some of the more well known italian banks are just now coming to grips with potential insolvency. boy, did they put that off for a long time -- just years and years and years of that and deutsch bank is in dreamland when it comes to somehow it believes things are hunky-dory despite relatively low reserves versus their potentially very expensive legal problems. deutsch bank has historically been totally clueless about the

basically to stick it to them for mortgage transgressions from the great recession. hence why without much due process at all, bank of america, jpmorgan and citigroup paid $17 billion, $13 billion, and $7 billion respectively. now it's deutsch bank's turn, and the justice department would like them to fork over $14 billion for their role in the crisis. deutsch, which only has between $5 billion and $6 billion in legal reserves, regards that suggestions as an opening bid in some kind of negotiation. cryan gave to a german media outlet, though, is one for the books, saying he hopes deutsch bank will be treated -- and i quote -- with the same fairness as american banks that have already agreed on a compromise, end quote. has he talked to any execs from these banks? has he talked to their attorneys? if he gets the same level of fairness they got, deutsch bank could end up needing a bailout.

the second sector that should have been rosy, retailers and restaurants. holy cow, these stocks have been bad. last night sonic, a pretty consistent fast food joint, pre-announced a truly dreadful number, which comes on the heels of a devastating number from none other than consistent cracker barrel. both of these companies should have been beneficiaries of lower gasoline prices and higher consumer confidence. nope, not at all. and the negative pin action? it's hammered the whole rest of the group. retail is no better. already beaten down macy's today. the stock's miserable trajectory has been a harbinger for most of the rest of retail, i guess save the price cutter that is walmart and the death star of the industry, which of course is amazon, which continues to go higher as it should. even the retailers that have been making a stand like urban outfitters, they've been smacked down beyond all recognition. this is all very extraordinary

consumer has in their pockets thanks to cheaper gasoline. oh, and nike, the once most steady of apparel companies, the giant, with u.s. sales flagging, it feels more like a retired nike missile even as i do think it is simply a matter of time before it regains its stature. more on that later. these stocks have become the third rail of investing. if you can avoid touching them, i recommend it. of course there's still plenty that is working. tech's been strong. the semiconductors stocks are up versus a 6% gain for the s&p 500. the faaa stocks -- that's facebook, amazon, alibaba, and alphabet -- have been running, but the latter got slapped with a sell call today that reverberated mightily. alphabet, sell call. geez, the stock is selling at market multiple. i didn't like that call at all. it's been apple that's been the real star, though, with the stock rallying from $95 to nearly $114 this whole quarter

including higher than expected sales and average selling prices for the iphone 7. an exploding phone from competitor samsung clearly superior optimal. and a new initiative announced today, this afternoon, with deloitte, a huge information technology consulting company that could make the enterprise the stickiest customers out there. finally tilt toward what the employees use, apple. you need to watch this deloitte deal's ramifications. it isn't tactical or a one-off. it's strategic, which means it the pressure off this whole how many cell phones did you sell today treadmill that apple has been on. wouldn't that be a godsend? here's the bottom line. as this quarter winds down, we have a paradox of banks and retailers and restaurants, what we thought would be the strongest stocks in 2016, devoid of footing, while tech stocks -- it's the opposite of what you might have expected a year ago, and it's a major reason why things feel mighty gloomy even as it looks like we were going to get out of the worst month of the year pretty much unscathed.

oil, the same thing that always works until, or course, it doesn't. david in new york, david. >> caller: hey, now, jim, what's going on? david in new york. >> man, i don't know. i'm just having a good time today. how about you? >> caller: sounds good. my question is regarding solar city. i really do believe in elon musk. he terms this merger as a no brainer, so my question to you, is this really a no brainer, or is he going to hit us with -- >> i got a reference at delivering alpha. he said solar city he felt basically was a company that may not even survive. that said, i was with someone last night. i took a ride in a tesla and then bought the stock. just like that. ride tesla, buy stock. as my great friend jim stewart, who is a fantastic writer said,

so tesla, the stock, i think you're still in a cult situation, and it's going to go higher. incredible. how about norman in california, norman? >> caller: hey, jim. big north hollywood booyah to you. >> i lived there for a while. booyah right back at you. >> caller: the reason i'm calling. i have some shared in a diversified construction company that has sizeable infrastructure and road-building division, and given the urgent need for upgrades in our infrastructure, how do you feel about fluor corporation, flr? >> you really want to be in martin marietta materials and vulcan materials. fluor, i regard as being an oil and gas play, and that's why i think you take advantage of this new rumor about a production cut and maybe even do some -- >> sell, sell, sell. >> this is far from the market many expected going into 2016, but as the quarter winds down, well, we got to go over restaurants, retail, financials.

in tech are helping us get through an ugly month, of course also a production cut rumor. on "mad money" tonight, with names such as sharpie, grayco, mr. coffee, elmer's, now newell is the product powerhouse that rules the aisles of retailers like a target and a walmart. can it also rule your portfolio? then is nike losing its footing in the sneaker market? i'm trying on a different play in sports apparel after the swoosh's slip-up today. and radius health is up. after a shaky start to 2016, is it still worth investing in a company that has the patch? i have the exclusive with the ceo. i suggest you stick with cramer. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail to madmoney@cnbc.com or give us a

miss something? head to madmoney.cnbc.com. josh, don't you have friends coming over? yeah, so? it stinks in here. you've got to wash this whole room are you kidding? wash it? let's wash it with febreze. for all the things you can't wash, use febreze... ...fabric refresher whoa hey mrs. walker inhales hey, it smells nice in here ...in one refill. pluggable febreze and fabric refresher... [inhale + exhale mnemonic] ...two more ways to breathe happy h. heartburn. sorry ma'am. no burning here. try new alka-seltzer heartburn relief gummies. they don't taste chalky and work fast. mmmm. incredible. can i try? she doesn't have heartburn. new alka-seltzer heartburn relief gummies. enjoy the relief. ?? dry spray?

it's already dry! no wait time. this is great. it's very soft. can i keep it? (laughter) all the care of dove... now in a dry antiperspirant spray. awarded best of beauty by allure. what are these? what is it? duck lips. quack quack. plastic surgery duck! uh huh! you are a backwards duck. instead of quack, he says- no, kcauq. kcauq. kcauqqq. kcauuuu. ? ? pringles! put some distance between you and temptation with meta appetite control. clinically proven to help reduce hunger between meals. "is that credit karma again?" doctor recommended brand. "just wanna see if my score changed..you wanna check yours?" "scores don't change that much. i haven't changed." "oh really?" "it's girls'night. ah huh." "they said business casual."

eah, maybe it is time. maybe i should check my credit score." "try credit karma. it's free." "oh woah. that's different." "check out credit karma today. credit karma. give yourself some credit." earlier this year, two terrific companies merged to create a consumer products powerhouse.

100 brands including everything from bicycle playing cards, mr. coffee machines, coleman camping gar. now the combined company calls itself newell brands. this is a holiday special. i've been recommending this stock since the deal was announced last december, and so far the stock has rallied more than 18% year-to-date not just because this is now featured in every store near you. actually i've never seen it before o t now, a number of the analyst who's cover the sector were hesitant to get behind newell brands because they feared the complexity of these two companies or they didn't like all the money newell was borrowing in order to pay for jarden. all along i've said this deal creates fabulous cost synergies and earnings boosts while diversifying the company's portfolio of products, meaning the positives, in my opinion, totally outweigh the potential negatives. i said in my opinion because not

been consummated for a few months, i am more confident than ever about newell brands, which is which wee recently added it to my charitable trust. i'm referring to myself and my co-manager. he and i have worked closely on this. let me explain why i think this stock makes a fabulous core holding for anyone's portfolio. [ blender whirring ] i like that. i like to put things in -- oh, thank you. our staff is always so good. i just have to do this. let's see if it works. like a charm. first of all, the old newell rubbermaid was itself a great company, maker of writing products, containers, baby products, including products like papermate, mr. sketch, rubbermaid, and sharpie. jarden on the other hand was a house of niche brands. they were number one in a ton of different categories like blenders.

food. yeah, put it all in. let's see what we come up with. blenders, slow cookers, coffee makers, sleeping bags, skis, tents, toothpicks, scented candles, and so on. now, these -- let's just give it some time. you have to give it some time. we have to change this in post-production. okay. fairly -- okay. so it doesn't work in all situations. when you zoom out, which we have to do while this works, they're both specialists within the durable goods businesses that also sell a bunch of high margin consumables. and as they put it on in the conference call, they both, quote, compete in large growing, unconsolidated global markets that have lost cost of growth and in categories that are responsive to innovation and

look at this innovation i've got going here. go ahead, give it a try. anyway, point two, these companies have combined in newell brands stronger than ever. the deal has increased scale. wow, they really -- this is going to be one nifty -- do you have any quinoa. giving them more bargaining power to distributors, more ability to compete overseas and online. newell brands is 2.2 times as large with its key strateg rubbermaid, and it's 2.4 times as large as the companies top 12 geographies. third -- just a second. let me see if it's ready. mmm, needs some yankee candle. third, many of these brands are extremely complementary. jarden and the old rubbermaid had baby care, commercial products, especially kitchenware. now they can combine these businesses not unlike my combining of these fabulous

what i really like about the deal is it took two consistent growers, companies that had been growing their total business at a healthy 4% to 5% clip for years and it put them together with the added advantage of some major cost savings. speaking of cost savings, the ceo has got a proven track record of cutting costs since he took the helm in newell rubbermaid in 2011, and martin franklin, the founder and former ceo of jarden, another great cost cutter is also on the board. so when newell brands talks cost synergies from this deal, i think they're being conservative, frankly. possibly very conservative. typically with large mergers, you see about a 5% reduction in lower costs. if you apply that number to newell brands, it could be looking at $700 million in savings. at the same time, on top of these cost synergies, management is confident that the jarden deal will be significantly additive to earnings. that's more of a long term

posted nearly 22% earnings growth. that's a phenomenal number driven mostly by adding jarden's brands to the portfolio. there's one more point. the old newell rubbermaid was disciplined about keeping its brands lean and having a narrow focus but jarden was with never willing to sell off any of its extraneous brands. i wouldn't be surprised to see newell branding selling off some of the more tepid businesses they got from jarden. what about all the the analysts talk about. many analysts pooh poohed the merger because they thought integrating jarden would be too difficult. i'll grant you, newell took on roughly 10 billion in dez to pay for jarden, which is a huge increase from the 3 billion of debt before the transaction. even with all this extra debt, moody's reaffirmed the rating of newells, saying they expected the company to immediately start paying it down. in the latest quarter, the company already paid down

getting the balance sheet under control asap. if newell brands keeps paying off its debt at this pace, this will become a better balance sheet story. what about the other objection, that it would be too hard to gobble up jarden and make it all work? here's the thing, both the old newell rubbermaid and jarden were already working through some major acquisitions when they announced their merger. newell was buying elmer's. no. save that. definitely save that. newell was buying elmer's, and jarden was buying joss ten's, the maker of class rings. the fact they even managed to get this merger done while they're handling all these other deals, incredibly impressive. so far, at least newell brands seem to be crushing it as far as integration of jarden is concerned. on their latest conference call from the end of july, mike polk

the jarden tax cost synergies, we are well on our way to deliver our $50 million to $80 million with a good probability of delivering toward the high end of the range. so we're on track and foresee no issues here and perhaps some opportunity, end quote. that sounds very good to me. if the commentary sounds similar when newell brands reports again a month from now, then i think the bears will need to eat some serious crow or at least this great dish i've concocted. we talked about newell brands the company, what about the stock? i think newell is cheap, putting it at a modest discount to the average stock on the s&p 500. edge well, that's a personal care spinoff from energizer, that sells at 20 times earnings. there's no way newell should be this cheap, especially since it got some multiyear growth thanks to the jarden deal. so let me give you the bottom line. i've liked the newell rubbermaid/jarden merger ever since it was announced roughly

consummated and we've gotten some numbers, i'm an even bigger fan of newell brands. that's why i put my charitable money where my mouth is and bought it from actionownersplus.com. it would make a great addition to your portfolio. amazing management, some tremendous cost savings catalysts. i don't know. what more could you ask for? much more "mad money" ahead. slow your stride. then approximately 10 million americans have osteoporosis, placing them at high risk. with few treatment options in sight, i'm eyeing one company trying to help solve the problem with a little device. and i've got one of the largest payroll players in the land. the stock took a hit after earnings today, but could the decline present an opportunity to buy? don't miss my exclusive with the head honcho of paychex.

whole darn thing. don't let dust and allergens get between you and life's beautiful moments. by choosing flonase, you're choosing more complete allergy relief and all the enjoyment that comes along with it. when we breathe in allergens, our bodies react by overproducing 6 key inflammatory substances. most allergy pills only control 1. flonase controls 6. and six is greater than one. with flonase, more complete relief flonase, six is greater than one, changes everything. ? ?when you've got...? ?...nausea, heartburn, indigestion, upset stomach, diarrhea!?

ah. ?nausea, heartburn, indigestion, upset stomach, diarrhea!? red 97! set! red 97! did you say 97? yes. you know, that reminds me of geico's 97% customer satisfaction rating. 97%? helped by geico's fast and friendly claims service. huh... ly as it gets. woo!

long knives were out for nike today and it didn't matter what the company had to say on that conference call last night. the combination of a 1% gain in north american futures orders, considered to be the best indicator of the company's future growth and a decline in gross margins crushed nike stock, took it down two bucks despite some tremendous growth in china and europe. it's a tough comeuppance for a company that increased its revenues from $16 billion in 2007 to $32 billion today.

selling of north america in the last few months causing nike stock to be the worst performer. the hidden culprit behind nike's weakness, the return of adidas to the fore never even came up as the company told the statement story as ever, as if all were well. and that more than anything else rankled the bulls and rankled yours truly. it was really reminiscent of the u.s. same-store sales decline below st yet unlike nike, starbucks ceo was willing to call it disappointing on his conference call. if you don't hear mea culpa off a big miss, then you tend not to believe the company can turn things around anytime soon. worse, when you hear explanations that offer one time excuses for the decline in gross margins instead of newfound competition, as well as a relatively hit and dismiss -- you know, kind of non-important

well, you get down right worried. you get down right worried despite the company's fabulous chinese and european numbers. futures orders don't mean that much anymore? wait a second. you taught us that they do. these are uncharted times, not just for nike but for its analyst acolytes, who have deservedly always found reasons to buttress owning the shares of this terrific company, while adidas wasn't blamed as part of the problem, we did get some questions on the call about whether athletic apparel had i wish the analysts had been more forceful on an athleisure slowdown question maybe, but i think you would have heard management say, well, nike isn't about that. it's about sports performance and innovation. they go hand in hand and everything else follows. they've always started with the athlete, and there are 7 billion athletes, at least what they say on the call. so the total adjustable market is still up for grabs. of course that's how many people are in the world. here's the issue i have with that concept. where in some new era where millennials may not buy into

sure, jordans still sell, and the kyrie, k.d., lebron are hitting the numbers. however, something is not resonating to explain the slowdown, and that's the company refusal to admit the slowdown exists. that makes it harder to figure out what's wrong? is the business going to under armour? is it going to adidas? is it going toward these retro, decidedly non-technology stan smith tennis from adidas, which i think is barely in the performance footwear category and is certainly not at the forefront of innovation, which happens to be nike's real hallmark. these are the hottest shoe in the world. now, of course, nike will say, wait a second, that's not fair about jordans. you've got the lebrons. but this is what's tearing up the world. sure, there were some excellent callouts in the exchange. i like what i heard about flex. that's that technology company and quick to market shoes.

ink story because of the emergence of industrial 3-d printing. nike's involvement with the apple watch facilitated through tim cook, that definitely resonates with me. still, though, i struggle to come up with reasons to buy this stock right here at 23 times earnings when i can pick up the sports wear panoply of all of these at foot locker for 14 times earnings. that's clearly the play here, not nike. more broadly, i also searched for a takeaway for lululemon, but i couldn't find one. bullish for lulu because it confirms the company is not a competitor with these guys but is going for a whole new brand of non-performance apparel based on yoga with a sideline in spinning and casual clothing. the bottom line is until nike admits the slowdown is for real in north america, they can't solve it. foot locker encompasses the ultimate win here, even if there's no slowdown as nike contends. while i find nike's domestic

too. edgar in colorado, ed guard? >> caller: jim, booyah, thanks tore faking my call. >> booyah right back, edgar. >> caller: so nike is a good segue to my question regarding guess. >> guess had a good quarter. >> caller: yeah, so my question is i'm wanting to pick it up to diversify my portfolio and add some retail exposure. 6% dividend yield. it's near its 52-week low. what do you think in. >> i'm going to have to say no, and i'll tell you why, edgar. i think -- i was halftime with judge wapner the other day. you know, fashion apparel has had another leg down. i had been buying into it for the month of august, and actually july too. but right now we got to wait. now you're going to get into tax law, that stock down almost 25%. be careful out there. the first step to solving a problem is admitting you have

impact of its competition. in the meantime, if you want exposure to sports apparel, i got an idea. why don't you consider the much cheaper foot locker. much more on "mad money" ahead. osteoporosis. i'm eyeing a company working on finding a solution. then paychex. with the fed's temporary rate hike off the table, i'm talking with the ceo fresh off earnings. and all your calls rapid fire on tonight's edition of the lightning round.

what the heck just happened to the stock of paychex, the second largest payroll processor in america? also an outsource provider of human resources and benefits. here's a stock moving steadily higher all year. then falling nearly three bucks or 4.6% today. why did it get hit? was the quarter a disa higher than expected revenue, up 8.6 year-over-year. those are good numbers. the problem was with the guidance. paychex slightly lowered their forecast for the 2017 fiscal year and investors always care more about the future than the actual results because i always tell you it doesn't matter what happens. it's about what's going to happen. however, there are some reasons to think the guidance cut isn't as bad as it looks. according to management they're

they also said their payroll service revenue growth, its main business, would come in somewhere between 2% to 4%. that's down from last quarter, not just a tax issue. we got to drill down. should we concerned about a softening in paychex business or are we getting a rare buying opportunity here in a stock that's been working its way higher for quite some time and, by the way, supports a 3.2% yield at these levels. let's talk to the ceo, martin mucci. money." >> thanks, jim. >> it is highly unusual for me to hear you do anything other than keep guidance, maybe even raise guidance a little -- i'm quoting from the conference call. you said service revenue growth anticipated to be in the range of 3% to 4%. we had said 4%, and from our perspective, it's fine tuning. from my perspective, i would have thought it might actually

so explain to me why i can't -- i should think that paychex didn't lose business to others. >> well, i think it is really fine-tuning. we had a guidance out there at about 4%, approximately 4%, and when you look at the year, we lost one payroll day this year compared to last year the way it falls, and we refined that. we refined it to be 3% to 4%, and we're always -- you know, we try to be on the conservative side of making sure there's no surprises, andre so we went with a little bit of fine-tuning there. i think it was a little overreaction. the stock is up 25% since last year, even where it is today, so we're pleased with that. by the way, the net income, there was some confusion on the call on the net income. the net income guidance didn't change. we just reported it on a gap basis versus non-gap. so we're still expecting that income when you remove the discreet tax items from both quarters, to be around 8% growth, which we think is solid

>> it was definitely a solid financial quarter, but you mentioned that the different -- the fine-tuning about the day. you obviously knew when you made your guidance that there was a difference in the number of days. why does it suddenly play a role this time? >> i think we looked a little closer at it, and we have some thought there that maybe we're not as close to 4%. that we're somewhere in that range. we decided to put more of a range around it. i don't think there's been any big surprises at all in the first quarter to us. again, it was a solid financia sales were up, and reps were fully staffed. our turnover is at its lowest point it's been. maybe a little overreaction to us being more cautious. >> there were questions about the competitive environment to try to isolate whether that was again the shade in guidance. you've reiterated it is not more competitive right now. it's pretty much business as usual. >> right. that's exactly right. we feel very strong about the products that we've been putting

handle the overtime new rules coming in december 1st. we feel very good about the product set. the service continues to be add record highs. so we feel very good about the competitive environment and about our ability to produce. so i think we'll be fine. >> it's some of the things i'm involved in. labor department, final overtime rules become effective december 1. it's going to span over time to millions of workers. how will an employer know what to do? >> well, basically the most important thing they've got to do is be sure they track that time. i mean you're talking about employees that typically made $23,000 or less. now it moves up to about a little over $47,000. as you said, that's impacting millions of employees, and so these companies that have not necessarily tracked time or been as careful, they really want to have a time and attendance solution where they're tracking time and making sure that

being sure that overtime hours aren't racking up for their employees that they didn't think about in the past. >> not everybody is a small and medium-sized business who watches. i know it because i use paychex. if you could explain to people what happens. the government comes in, and if they think you're doing it yourself, they're suspicious. if you have an outside company, they're likely to think you're doing it right. business, and we've been in time and attendance for over five years. we have tens of thousands of clients on time and attendance. so they're going to know that, hey, i'm expecting that the products and the software and the technology that we're using to track time and report time and pay the right wage for that overtime is going to be correct. if you don't have anyone, they're probably a little more likely to go in and do some compliance audits or, you know, possibly enforce some penalties on you.

any areas of the country surprisingly stronger? i know that you've got -- we've seen state of washington be good. i know we've seen some of the midwest not be so good. where are we right now? >> yeah, right now the east -- it's a tale of two coasts. the east coast has been coming on stronger, particularly the southeast. i think home building is back up. prices are coming back up on some of the more expensive homes, so you're seeing construction build up. the west coast kind of saw their growth early, jim, and so that's coming down a little bit and flattening out some. and the middle of the country, you know, still in the more negative range because of energy jobs and fracking and so forth, and manufacturing, you know, still not strong of course because of the strong dollar. so we're hoping things will -- you know, it's been positive, growth and jobs, but slower. and we'll have to hope that the election doesn't have much of an impact on that. hopefully it will pick up. >> well, that's my thinking too. martin mucci, the president and ceo of paychex, always good to see you, sir. thank you so much. >> thank you. "mad money" is back after the

unstopables in-wash scent boosters. the more you pour the more scent you'll savor. toss into your wash before your clothes for luxurious scent for up to 12 weeks. and introducing unstopables fabric conditioner by downy giving your laundry a bold, captivating scent with luxury you can feel. for long-lasting scent, just pair with your in-wash scent booster. unstopables by downy. the ultimate in long lasting scent. ?? ?? that's fun. ?? it's already dry! no wait time. this is great. it's very soft. can i keep it? (laughter) all the care of dove... now in a dry antiperspirant spray.

>> it is time! it's time for the lightning round! you'll hear this sound -- [ buzzer ] -- and then the lightning round is over. are you ready, skee-daddy? it's time for the lightning round on cramer's "mad money." i'm going to start with bill in california, bill. >> caller: booyah from marina del rey, california, jim. >> so beautiful. what's up? >> caller: you always say to look for value in today's market, and i think i found an undervalued stock in aar corporation. >> i like the aircraft service business, always have. you're absolutely right. our viewers are very smart. paul in florida, paul. >> caller: hey, jim.

what's happening? >> caller: okay. i'm talking about b/e aerospace. i did a lot of research. >> i do like it. it did have a couple of bad quarters and it did try to at one point sell itself. i do like it, but let's be a little bit careful of aerospace in general because we know that boeing's numbers were a little squishy last time around. let a go to susie in kansas, susie. >> caller: hi, jim. this is susie in kansas. >> how are you? >> caller: i'm fine. i was in your special class on june 10th of 2015, and you recommended biotherapeutics, atara -- >> good spec. i reiterate good spec. these are working right now. they are working. let's go to dwayne in tennessee, dwayne. >> caller: booyah, jim. >> booyah. >> caller: how about them eagles? >> yeah, go eagles. >> suncoke energy.

i think if you like this group, you're going to like tech resources more. thank you to mr. bishop from delivering alpha. i'm taking one more. let's go to don in ohio, don. >> caller: cramer, this is don from ohio. big buckeye booyah to you. >> what's going on? >> caller: i'd like your opinion on lumentum holdings, lite. >> this is a red hot stock, and i've got to tell you, it's a telecommunat like, but i like cisco more because i am far more conservative and don't want to risk a stock that sells at a gigantic multiple, although next year could be very good earnings. that, ladies and gentlemen, is the conclusion of the lightning round. >> announcer: the lightning round is sponsored by td ameritrade. but you have got a full day ahead of you, try mucinex 12-hour. only mucinex has a unique bi-layer tablet.

while the blue extended release layer lasts a full 12 hours. relieve chest congestion with mucinex, and enjoy living well. what are these? what is it? duck lips. quack quack. plastic surgery duck! uh huh! you are a backwards duck. instead of quack, he says- no, kcauq. kcauq. kcauqqq. kcauuuu. ? ? "whatcha doin?" "just checking my free credit score at credit karma. "what the?" "don't you know that checking your credit score lowers it." "actually, checking your own credit score with credit karma doesn't affect it at all." "i guess i could just check my credit score then." "check out credit karma today." question, are my teeth yellow? have you tried the tissue test? ugh yellow. what do you use? crest whitestrps. crest 3d whitestrips whiten 25 times better than a leading whitening toothpaste i passed the tissue test.

are the way to whiten. some of the smaller biotech stocks have come roaring back from their lows over this year although most of these names are still off their 2015 highs. take radius health, a biotech company focused on treating osteoporosis and other endocrine-mediated disorders.

from its february lows though it's still down 5% year-to-date. now, a radius drug is a treatment for osteoporosis in postmenopausal women is just waiting on the fda to make a decision. we'll know whether that gets approved by march 30 of next year. the company just published some positive phase three clinical trial data showing it did a terrific job increasing bone density and preventing fractures. at the same had some promising results with a transdermal patch version. they also have an early stage treatment for a certain type of breast cancer that's still in phase one. it's been mostly marking time, trading sideways over the past six weeks. you have to wonder has it run out of steam or is this a pause that refreshes before another move higher? the company had its annual investor day today, so let's take a look at bob ward. he's the president of radius

welcome back to "mad money." >> thank you, jim. great to be here. >> when i was reviewing the notes, a lot of people were excited. two different things they're excited about. one is we got to talk about the breast cancer, and how those tests are going, but the patch seems like a real breakthrough versus what's out there now. let's talk patch. let's talk price of patch. let's talk what it means. >> well, what patch means is today, jim, the market leading product from eli lilly, forteo we developed a subcutaneous application because patch has been difficult for people to get right. what was super exciting was the new data where we've shown that a short wear time patch that would be put on, we estimate five minutes once a day, could be a potential replacement for what would be considered for a typical subq. now, these are microneedles, so they only penetrate the top layer of the skin, not even deep enough to feel.

the different? how does that work versus this? >> well, that's a pen that you use for a period of time and a daily subcutaneous injection, but it's a very small volume. >> okay. so cost? is this much cheaper? >> well, for osteoporosis, the cost of treatment is really a couple of different things. >> okay. >> this year in america, more patients will be hospitalized for a longer period of time with osteoporotic infrastructures that are hospitalized for myocardial infarct. >> this can put people in hospitals more, and once they're in hospitals, fatality right? >> there's mortality associated with fracture, but it's preventing that next fracture. there's a window of an opportunity to come in with anabolics that build bone to reduce the risk of the next fracture. >> because there's so many political issues these days involving drugs, how much can this save the system versus what we have right now? >> one of the things we talked

bone and mineral research was what's called number needed to treat. this is the question of how many patients would you have to treat to avoid one fracture? and the numbers that we showed are really remarkably low. not too dissimilar. remember, with an hmg-coa, if you treat 100 patients, you avoid a myocardial infarct, we show that our numbers are well lower than 100 to treat to avoid. we think the ratio is the right ratio. >> lilly is a powerful company. lilly has patents. lilly could go to doctors and say we don't want you to use that. what is the system set up so that the income bent -- does the incumbent have a big edge over you? >> it's really down to clinical data for physicians leads to a decision of which drug to choose. >> lilly could have all the

if the clinical data is better, radius wins? >> well, in the u.s. today, there's a large number of patients who we have that an osteoporotic fracture may not be diagnosed and may not be offered treatment. so if you said in our health care system today is there a need to fix what happens for osteoporotic patients, absolutely. and lee yea sons are there to connect patients up. there are some issues around systemic care we want to change. >> all right. last question, some people were very -- you know, the receptors in breast cancer, which is very early on, but it's something we're very excited about what they saw today. if you can give our audience a sense without too much hope because i know it's very far -- >> well, in breast cancer, we have two different molecules. one is very early. it's not yet been tested in humans. so this is an early-stage investigational drug that hits a new pathway for -- >> we have charles river labs on

rats or just on the bulletin board? >> for round 140, it's something that's currently being tested in rats. but for 1901, we have a phase one trial in advanced metastatic breast cancer. we have confirmed clinical responses, and we're reporting that in december this year. the clinical results from that trial. >> then you have to come back when you do that. congratulations on this little patch that obviously can save the system a lot and maybe save some lives more importantly. thank you so much. that's bob ward, president and ceo of radius health. this seems like very special technology. stick with cramer. is that ice-t? nope, it's lemonade. is that ice-t? lemonade. ice-t? what's with these people, man? lemonade, read the sign. lemonade. read it. ok. delicious. ice-t at a lemonade stand? surprising. what's not surprising?

it's lemonade, man! fifteen minutes could save you fifteen percent or more. it's the phillips' lady! anyone ever have occasional constipation, diarrhea, gas or bloating? [ simultaneously ] she does. help defend against those digestive issues. take phillips' colon health probiotic caps daily with three types of good bacteria. 400 likes? wow! phillips. be good to your gut. my sweethearts gone sayonara. this scarf all thats left to remem...

have you guys been watching the stock of caterpillar? this thing has been on fire. it is going up, going up, going up. it's at 85. that's the breakout level according to bruce kamich from realmoney.com, and it's because mining is coming back, and asia retail sales numbers for cat are

i like it. i like to say there's always a bull market somewhere. i promise to t ? i saved her job because they wanted to fire her for putting on so much weight. >> if a candidate regularly and flippantly makes cruel and insulting comments about women, about how we look. >> the rhetoric heat up along the conflicting reports about the state of the trump campaign. and then world leaders anyone? another cringe worthy aleppo moment for libertarian presidential candidate gary johnson. and details on the teen who opened fire at elementary school. who may have also fatally shot his own father. >> and then a wild scene of a